Does your child have Neuroblastoma'? Let's learn about the Dinutuximab vaccine!

I understand how heavy it must be to know that your little one has a disease like `Neuroblastoma`. At such a time, a thousand questions come to mind, and you feel sad and scared. But remember, medical science is very advanced these days. So, there are treatments that can be given for such conditions. One such special medicine is `Dinutuximab`. Today, we will talk simply about this `Dinutuximab` vaccine, how to give it to the child, and what things to be careful about.

What kind of medicine is `Dinutuximab`?

Simply put, `Dinutuximab` is a drug that belongs to a special class of drugs called `Monoclonal Antibody` . Think about it, don't we have an immune system in our bodies that fights diseases? Similarly, this `Monoclonal Antibody` is also a protein specially made in the laboratory. The specialty of this one is that it is made to directly target and attack specific cells, such as cancer cells. `Dinutuximab` is used specifically to treat a type of cancer called `Neuroblastoma`, which occurs in children .

You may see this medicine under the brand name `Unituxin`. This is not a common medicine, but a very powerful medicine that is given under the supervision of specialist doctors. Therefore, it is very important to have a good understanding of this.

In what situations is this medicine given to children?

As I mentioned earlier, `Dinutuximab` is mainly used to treat a cancer called `Neuroblastoma` that occurs in young children, that is, children as young as 1 year old . `Neuroblastoma` is a type of cancer that occurs in the nervous system. It is a cancer that is commonly seen in children.

Sometimes, doctors may decide to use this medicine for other medical conditions. But only the doctor can decide after carefully examining your child's condition. Therefore, ask your doctor or pharmacist any questions you may have about using this medicine.

What are the important things to tell the doctor before starting the medication?

This is very important. Before starting `Dinutuximab` treatment, it is important to inform the medical team about certain information about your child's health condition. Because the success and safety of the treatment depends on that information.

Here are some things to definitely say:

• Current infections: If the child currently has an infection, such as a fever or cold.
• Kidney disease: If the child has any kidney-related problems.
• Liver disease: If you have any liver related condition.
• Low blood cell count: This means that you have been diagnosed with a low white blood cell count, red blood cell count, or platelet count . When these levels are low, you can easily get infections and bleed.
• Lung or breathing disease: Conditions such as difficulty breathing, asthma.
• Pregnancy: Even if a child is taking this medicine, the person taking the medicine (e.g. the mother) should be informed if she is pregnant or thinks she may be pregnant (especially considering the environment and handling of the medicine). (This does not refer to the child becoming pregnant, but it may be important to mention the mother or caregiver. Or, if a young girl is taking this medicine, this should be discussed specifically. In the original article, "Do not become pregnant while taking this medicine" refers to the person taking the medicine.) In particular, if your daughter is taking this medicine, if she is pregnant, planning to become pregnant, or if you suspect she may be pregnant, you should tell your doctor immediately.
• Breastfeeding: If you are breastfeeding your baby. (This also applies to breastfeeding your baby if you are a mother taking this medicine.)
• Allergic reaction: If your child has an allergy to Dinutuximab, any other medicine, food, dyes, or preservatives, it is important to tell them .

Telling the doctor about these things without hiding them is very important for the child's safety.

How do you give this medicine to a child?

`Dinutuximab` is not a medicine that you take at home as a pill. It is given to the child as an `infusion into a vein` . Just like giving saline.

This treatment is given in a hospital or clinic by a trained doctor or nurse . So they will closely monitor your child when they are given this medicine. This is not a medicine that you can take home.

Talk to your pediatrician about giving this medicine to your child. In some selected cases, this medicine can be given to children as young as one year old . However, there are special precautions and concerns.

What to do if the medication dose is increased?

In rare cases, if you think your child has been given too much of this medicine, call a poison control center or hospital emergency room immediately . Don't waste time.

Important: This medicine has been prescribed for your child only. Do not give this medicine to anyone else for any reason .

What if I miss a medication appointment?

It is very important to give the medication on time and not skip doses. If for some reason you are unable to go to the hospital/clinic to give your child the medication on the scheduled day, call your doctor or healthcare professional immediately and let them know . They will tell you what to do next.

Can this medicine interact with other medications?

The interactions between dinutuximab and other medications your child may be taking have not yet been fully studied. This means that there is a possibility that some medications may cause problems when taken with it.

Therefore, give your doctor a complete list of all the medications your child is taking, including vitamins, herbs, non-prescription drugs, and dietary supplements. Also, tell your child (if they are an adult) if they smoke , drink alcohol, or use other drugs. Some things can interact with this medicine.

What should you pay special attention to when giving medication?

Your child may feel a little unwell or generally unwell while taking this medicine. This may be normal or may be a sign of a side effect. Therefore, if you notice any new symptoms or changes, tell your doctor . You should continue taking the medicine as prescribed, even if you feel unwell, until your doctor tells you to stop.

Pay special attention to these things:

• Changes in vision: If your child's vision seems blurry, has difficulty seeing in bright light, or notices any changes in vision , tell your doctor immediately .
• Serious allergic reactions: This medicine can sometimes cause serious allergic reactions. To reduce this risk, doctors will give your child other medicines before giving Dinutuximab. Give the medicine exactly as prescribed.
• Signs of infection: If your child has a fever, chills, or other symptoms of a cold, such as a sore throat, cough, or runny nose , call your doctor right away . Do not self-medicate. This medicine can reduce your child's ability to fight infections. Therefore, try to keep your child away from people who are sick as much as possible .
• Pregnancy (for young women): If you are a young woman taking this medicine, you should avoid becoming pregnant while taking the medicine and for 2 months after stopping the medicine . If you are planning to become pregnant or suspect that you are pregnant, tell your doctor immediately. This medicine can cause serious side effects in an unborn baby. Ask your doctor or pharmacist for more information.
• Breastfeeding: Do not breastfeed your baby while taking this medicine.

What are the possible side effects of this medicine?

Like all medications, Dinutuximab can cause some side effects. Some of them should be reported to your doctor immediately. Some of them are usually not serious, but if they persist and become bothersome, you should tell your doctor .

Side effects that should be reported to your doctor or healthcare professional immediately:

• Allergic reactions: Skin rashes, itching, eczema-like conditions, swelling of the face, lips, or tongue.
• Blood in the urine.
• Changes in vision: Blurred vision, sensitivity to light (difficulty seeing).
• Low blood counts: This medicine can cause a decrease in the number of white blood cells, red blood cells, and platelets. This can increase the risk of infection and bleeding.
• Pain, tingling, numbness in the hands or feet.
• Seizures.
• Severe headaches.
• Signs of infection: fever or chills, cough, sore throat.
• Signs and symptoms of low blood pressure: dizziness, fainting, fainting, unusual tiredness or weakness.
• Signs and symptoms of low potassium: muscle twitching or pain, chest pain, dizziness, fainting, difficulty breathing, fast or irregular heartbeat.
• Swelling of the ankles, feet, hands.
• Excessive fatigue (`tiredness`).
• Trouble passing urine or change in the amount of urine.
• Weight gain.

Side effects that do not usually require medical advice, but should be reported to your doctor if they persist or are bothersome:

• Diarrhea.
• Loss of appetite.
• Vomiting.

Important: This list does not include all possible side effects. If your child experiences any other symptoms, please consult your doctor.

How do you store this medicine?

You don't have to worry about this. Since `Dinutuximab` is a medicine given in a hospital or clinic, you don't have to take it home and keep it. So you don't need to worry about the medicine going bad or getting it into your children's hands.

Finally, things to remember (Take-Home Message)

`Dinutuximab` is a very important and powerful drug given for a serious cancer condition like `Neuroblastoma`. During this treatment, you need to be very careful about the child. Just as doctors and nurses are constantly checking on the child's condition, it is very important for you, as parents, to be attentive to the child's changes and side effects.

• If you notice any small changes or concerns, tell your doctor immediately. Don't be shy or ignore it as something minor.
• Follow your doctor's instructions exactly. Don't miss medication appointments or check-ups.
• Take heart. This journey is not one you go through alone. Doctors, nurses, family, and friends are all with you.

I hope this information has helped you gain some understanding of this medicine. I wish your child a speedy recovery!

` Dinutuximab, Neuroblastoma, Cancer, Childhood Cancer, Monoclonal Antibody, Vaccine, Side Effects